Insulet Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
(firmenpresse) - BILLERICA, MA -- (Marketwired) -- 01/05/15 -- Insulet Corporation (NASDAQ: PODD), the leader in technology with its OmniPod® Insulin Management System, plans to participate in the 33rd Annual J.P. Morgan Healthcare Conference taking place in San Francisco. Management is scheduled to present an overview of the Company on Wednesday, January 14, 2015 at 1:30 p.m. Pacific Time.
During this presentation, material information concerning the Company, its operations, strategies and prospects may be discussed. To listen to an audio webcast of the presentation during the event, please visit: . A replay of the webcast will be available for 10 days after the presentation.
Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its OmniPod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The OmniPod is a revolutionary and easy-to-use tubeless insulin pump that features just two parts and a fully-automated cannula insertion. Insulet''s subsidiary, Neighborhood Diabetes, is a leading distributor of diabetes products and supplies, delivered through a high touch customer service model. To read inspiring stories of people with diabetes living their lives to the fullest with OmniPod, visit our customer blog, Suite D: . Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: .
Insulet Corporation
877-PODD-IR1 (877-763-3471)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 05.01.2015 - 15:15 Uhr
Sprache: Deutsch
News-ID 1328115
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
BILLERICA, MA
Phone:
Kategorie:
Medical Devices
Anmerkungen:
Diese Pressemitteilung wurde bisher 251 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Insulet Corporation to Present at the 33rd Annual J.P. Morgan Healthcare Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von
Insulet Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
